OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
August 02, 2019
Complex and potent molecules demand greater technical and regulatory expertise to ensure safe handling.
August 01, 2019
A one-size-fits-all strategy is not the best approach for the development of a chemistry, manufacturing, and controls program.
Now that the first genetically modified cell therapies are being manufactured, the industry must move beyond “whatever works” to meet growing demand.
Does the pharmaceutical industry have adequate access to contained equipment, facilities, and infrastructure for the manufacture of highly potent APIs?
Key considerations when searching for an analytical service provider include workflow, hardware, and regulatory support.
July 30, 2019
Cambrex has revealed that it is expanding its solid form screening and crystallization process development facility in Edinburgh, Scotland.
July 17, 2019
Catalent Biologics has entered into a long-term strategic agreement to develop and manufacture an AveXis gene therapy treatment for spinal muscular atrophy (SMA), Zolgensma.
Catalent recently held a groundbreaking ceremony at its Bloomington, Indiana pharmaceutical fill/finish site.
July 16, 2019
An agreement with Sanofi gives Catalent access to commercial spray drying facility in Haverhill, UK.
July 12, 2019
CatSci has received two accolades from Welsh organizations, demonstrating its contributions to the Welsh economy in the field of process R&D.